Kapocsi J, Somogyi G T, Ludvig N, Serfozo P, Harsing L G, Woods R J, Vizi E S
Neurochem Res. 1987 Feb;12(2):141-7. doi: 10.1007/BF00979530.
Neurochemical and pharmacological evidence has been obtained that noradrenergic varicosities (in mouse and rat vas deferens) and cholinergic varicosities (in the Auerbach's plexus) contain heterogenous alpha 2-adrenoceptors through which the release of [3H]noradrenaline and [3H]acetylcholine can be modulated. The quantitative data also support the hypothesis that different noradrenaline and xylazine sensitive alpha 2-adrenoceptors are present prejunctionally in the vas deferens and Auerbach's plexus preparations. Prazosin, although it has a presynaptic inhibitory effect on alpha 2-adrenoceptors of noradrenergic axon terminals, has no effect on cholinergic axon terminals. These data suggest that there are two different types of alpha 2-adrenoceptors at the presynaptic axon terminals.
已经获得神经化学和药理学证据,表明去甲肾上腺素能曲张体(在小鼠和大鼠输精管中)和胆碱能曲张体(在奥尔巴赫神经丛中)含有异质性α2-肾上腺素能受体,通过这些受体可以调节[3H]去甲肾上腺素和[3H]乙酰胆碱的释放。定量数据也支持这样的假说,即在输精管和奥尔巴赫神经丛制剂中,不同的对去甲肾上腺素和赛拉嗪敏感的α2-肾上腺素能受体存在于突触前。哌唑嗪虽然对去甲肾上腺素能轴突终末的α2-肾上腺素能受体有突触前抑制作用,但对胆碱能轴突终末没有作用。这些数据表明,突触前轴突终末存在两种不同类型的α2-肾上腺素能受体。